Big news for the NF1 community: Selumetinib is now FDA-approved for inoperable plexiform neurofibromas. A major step forward in treatment options for Neurofibromatosis Type 1!
🔗 Read the full FDA announcement at: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selumetinib-pediatric-patients-1-year-age-and-older-neurofibromatosis-type-1